Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PARL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RCC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGC16275 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
WDR46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACOT9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NUDT22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMTC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYRM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUCY1B3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAGLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERCC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on